AI-driven small-molecule drug discovery platform (GEMS)
Founders
Evan Feinberg(United States · ♂)— After a Yale physics degree and a Stanford PhD in computational biophysics where he built the PotentialNet ML framework for drug discovery, he founded Genesis Therapeutics to apply AI to small-molecule drug discovery.
Team & hubs
In the network
Shares the most investors with (number = shared investors):